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Particle toxicology arose in order to understand the mechanisms of adverse effects of 3 major particle types
that had historically exerted the greatest toll of ill-health—quartz, coal and asbestos. By the middle of the last
century rat inhalation studies had been carried out and the pathology documented, but true mechanistic particle
toxicology did not really take off until the 1970s when cell culture techniques became available. By the 1980s
glass fibres were a major focus of interest and attempts to develop a structure-toxicity paradigm centred on
biopersistence. In the 1990s environmental particles dominated the particle toxicology agenda and the
cardiovascular system emerged as a target for inhaled particles, raising new challenges for particle toxicologists.
We are currently in the era of nanotoxicology where a large and diverse range of new nanoparticles types are
under scrutiny.The aims of particle toxicology are generally those of
conventional chemical toxicology, that is to investigate
the characteristics of particles that determine their abil-
ity to cause harm and the pathobiological mechanism of
that harm. Achievement of these aims should enable
identification of the best metric to measure particles in
order to manage their risk and to intervene in cases
where exposure has occurred in order to try to prevent
progression. Particle toxicology has problems that other
branches of toxicology don’t have, central to which is
the variation amongst the particles that are being
tested—a problem that continues to confound efforts to
make generalisations about their toxicology. This has
most recently been found in the sub-specialty of nano-
toxicology where the idea that all nanoparticles are equal
in toxicity has been slow to counter [1]. Many new
recruits to particle toxicology have taken up this area of
toxicology because of the flow of funding into nanotoxi-
cology, and we feel it may be helpful to them to know
something of the previous history of particle toxicology,
of which they may not be aware. While there are other
ways in which particles might have adverse effects, our
definition of particle toxicology is restricted to inhalation
toxicology, meaning the accidental inhalation of particles
in workplaces and the environment. A short history of* Correspondence: ken.donaldson@ed.ac.uk
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complements shorter accounts by other authors [2-5].
This is a personal history involving our own perception
of the landmarks; a different close observer of the last
40 years of particle toxicology might write a different
history. In such a short history it was impossible to
cover the work of all the particle toxicologists who
have advanced our discipline and we apologise for any
such omissions. A lengthier history would be necessary
to correct these.
The first descriptions of dust-related occupational
lung disease
The first mentions of a link between exposure to dust
particles and lung disease are to be found in the 15th
and 16th centuries. Within a few years of the invention
of the printing press, Georgius Agricola wrote about the
theory and practice of metal mining and refining in ‘On
the nature of minerals’ (De re metallica) (Figure 1).
Agricola described the theory and practice of mining
including finding seams and working them. However he
also described how air becomes stagnant in the mines
and he described machines to blow fresh air into the
mines, early ventilation systems. Along with accidents
adversely affecting the miners he also mentioned how
‘dust which is stirred by digging, penetrates into the
windpipes and lungs and produces difficulty in breathing
and the disease which the Greeks call asthma’. It is
important to point out that this is not our current use of
the term asthma but a generic term for breathlessness.ed Central Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
Figure 1 The front page of De re metallica (copyright expired; obtained through (Wikipedia commons).
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women are found who have married seven husbands, all
of whom this terrible consumption has carried to a pre-
mature death ‘. At that time no distinction was made be-
tween different lung diseases but later it was discovered
that the miners were at risk from three diseases, silicosis,
tuberculosis and lung cancer, all of which are likely to
have contributed to their early demise [2]. Agricola did
not link the dust exposure directly to the disease,
although he recommends a primitive dust mask in the
form of ‘veils’ that miners should wear. He is also
regarded as the father of occupational hygiene in his
description of methods of ventilating mines. Perhaps we
should not be too surprised of the lack of simple obser-
vational correlation between dust in the air and lung
disease since Agricola also wrote an entire book aboutthe demons (De Animantibus Subterraneis) that inhabit
mines. These ran about in the darkness chattering and
turning out the miners’ lamps but could be vanquished
by fasting and prayer!
Paracelsus, best known for his observations on dose in
toxicology and for his promotion of the first real cure,
mercury, for syphilis, published the first book devoted to
occupational disease in 1567. The term contrarian might
have been coined for Paracelsus. In an extended ‘gap
year’ following graduation in medicine he wandered
around Europe meeting all sorts of people from gypsies
to midwives and executioners and formed his own brand
of folk medicine. On returning in 1526 he became town
physician in Basel and lecturer in the University. Para-
celsus soon started publicly burning the previous genera-
tion’s medical textbooks and giving long, hugely popular
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of these made him unpopular with his colleagues. Of
relevance, he used his experience of smelting plants and
mines that he visited during his travels and his work for
mines in later years, to develop a theory of pathology in
miners’ lungs. He recognised and described the symp-
toms of miners’ lung disease—dyspnoea, cough and
wasting. Like Agricola he failed to make the link to their
exposures and instead evoked a theory involving ‘. . .the
powers of the stars, in that their peculiar characters are
boiled out which settle on the lungs in different ways’ [2].
Concepts of medicine were dominated in those days by
belief in disease being inflicted by demons or a conse-
quence of an imbalance of the humours, so these expla-
nations would not have been particularly strange to
Paracelsus’ contemporaries.
The person recognised as the father of occupational
medicine was however Bernardino Ramazzini, who in
1700 wrote his text ‘Diseases of workers’. His most
important insight was to recognise that illness could
have an environmental cause. There was a view that dis-
ease was sometimes caused by bad air (eg malaria from
Italian, mala aria) but he extended this to a much wider
range of factors. He also was one of the first doctors to
concern himself with illness in poor working people.
Amongst many insights on occupational diseases, for
that time, he discussed ergonomics / bad posture,
recommended that there should be good ventilation in
dusty trades, spacious rooms with a good draught, and
that workers should quit work at the first sign of any
lung disease [3].
Despite these early insights, the working conditions of
the poor, which included miners and those in dusty
trades, were of no interest to legislators until the Indus-
trial Revolution in the early 19th century and little was
done to protect workers from danger until the early 20th
century. From then on, in the developed world, steps
have been taken to reduce exposures in workplaces, by
which time exposures to the big three hazards, quartz
(crystalline silica), coal and asbestos had exerted a huge
toll in terms of particle-related lung disease, and this
continues in industrially developing countries to the
present day. Sometimes the scientific establishment took
the risks rather too lightly. For example J.S Haldane who
was honorary Director of the Mining Research labora-
tory of the University of Birmingham declared in 1923
that ‘the inhalation of coal dust causes no danger to life
but on the contrary gives protection against the develop-
ment of tuberculosis’. At that time silica was well known
to cause lung disease but the respiratory illness among
coal miners was thought to be a consequence of tuber-
culosis and quartz. Although he had a medical degree,
Haldane, a physiologist, was most interested in acute
problems such as gassing, explosions and pressureeffects, and it was not until pathologists in Cardiff such
as Cumming and Gough investigated the lungs of miners
in the period 1930–50 that it became apparent that coal
dust was toxic in its own right [6,7]. This of course was
also partly a consequence of the introduction of medical
radiology in that era.
The ‘big three’ of particle toxicology
Three particle types have been responsible for the great-
est amount of lung disease over time and these are dealt
with below.
Quartz or crystalline silica is one of the most common
minerals in the earth’s crust so that throughout the ages
whenever mankind (and they were mostly, but not
exclusively men) mined, quarried or worked the surface
layers of the earth, they were exposed to quartz dust as
the large crystals fractured into respirable particles. This
toll of death from silicosis was recognised first in the
18th and early 19th centuries among knife grinders in
Sheffield and men who made millstones, but undoubt-
edly went unnoticed from the time that men shaped
arrow heads and axes from flint. Lung cancer in miners,
subsequently shown to be due to radon exposure, was
first described at the end of the 19th century. In the
1920s the Hawk’s Nest tunnel incident in Gauley Bridge,
West Virginia, produced a horrific toll of death and dis-
ease (Figure 2). Of the estimated 2,500 workers who
worked in the tunnel, 764 died from acute silicosis and
an additional 1,500 ultimately developed the disease [8].
Although the employers attempted to cover this up, the
details can be read about owing to the fascinating
detective work of Martin Cherniack in his book ‘The
Hawk’s Nest Incident’ [9]. Unfortunately, silicosis con-
tinues to take its toll of human lives, even in developed
countries, though to a much greater extent in poorer
countries with inadequate regulation of exposed trades.
Asbestos was first mined in substantial amounts in the
late 1800 s in Canada and was soon being imported in
millions of tons per annum from the major producers,
Canada, Russia, South Africa and Australia into most
developed countries, where it was incorporated into a
huge number of products such as cement, tiles, fillers,
brake linings, pipes and insulation (Figure 3). Like
quartz, asbestos is crystalline and the crystals shatter
along fracture planes to release thin fibres that are easily
breathed in to the lungs. Asbestos causes a number of
lung diseases including asbestosis, a fatal type of intersti-
tial lung fibrosis, and lung cancer but also affects the
pleura for reasons that are becoming better understood
[10]. In the pleura it gives rise to pleural fibrosis, plaques
and mesothelioma, the most feared of the asbestos dis-
eases. Pleural effects in humans, especially mesotheli-
oma, have only been seen with asbestos and one other
long fibre-shaped particle, erionite, that is not part of
Figure 2 Hawk’s Nest Tunnel memorial in Ansted, Fayette County, West Virginia, USA. (From the Historical Markers Database http://www.
hmdb.org/marker.asp?marker=34417).
Donaldson and Seaton Particle and Fibre Toxicology 2012, 9:13 Page 4 of 12
http://www.particleandfibretoxicology.com/content/9/1/13the asbestos family; pleural effects are not seen with
other particles except in very advanced silicosis and
mesothelioma is only seen with fibres. Mesothelioma is a
slow-growing but highly malignant tumour that causes
death usually within a year or two of diagnosis, with no
known cure. Although asbestos is no longer used in
most developed countries, in many countries it still is,
and exposure still occurs from its removal or disturb-
ance. In Western countries thousands of mesothelioma
deaths occur every year owing to the use of asbestos
until the 1980s and this is likely to continue for decades
in most countries, particularly where amphibole asbestos
has been used [11].
Coal causes a form of pneumoconiosis (coal-worker’s
pneumoconiosis) that is usually less severe than silicosis.
Coalmine dust comprises mostly low toxicity particles
containing a variable mixture of carbon, quartz and sili-
cates, and coalworker’s pneumoconiosis is a lung disease
caused by large accumulations of coal dust-laden macro-
phages with a modest local tissue reaction of mild fibro-
sis usually accompanied by emphysema (Figure 4). In a
significant proportion of individuals it develops into
progressive massive fibrosis, probably related to accumu-
lation of very high lung burdens caused by the dust-
induced inflammatory reaction in draining lymph nodes
blocking clearance [12].In the middle of the 20th century the UK National
Coal Board’s ‘Pneumoconiosis Field Research’ devel-
oped an integrated approach to understanding the link
between coalmine dust exposures and coal worker’s pneu-
moconiosis, using epidemiologists, hygienists, pathologists
and radiologists. Radiographs of coal workers were used
to monitor prevalence of the disease and the risk of this
was related to measured dust exposures of the miners.
In addition, the extent of the disease in many of the
miners’ lungs was assessed at autopsy. The ambitious aim
was to determine the elements of the coalmine dust
(quartz, clays, coal itself) that were responsible for disease.
This analysis was carried out in the Institute of Occupa-
tional Medicine in Edinburgh. This huge undertaking ini-
tially involved the development of a sampler (MRE114A)
that was critical for determining exposures to respirable
dust. In fact when the huge amounts of data were brought
together, including more than 30,000 chest radiographs
alone, the conclusion was clear—no single component of
the coalmine dust mix was responsible and the total res-
pirable dust was the metric that was best related to disease
development. The exposure-response relationship calcu-
lated by Michael Jacobsen and colleagues led to agreement
between trades unions, employers and government on a
coalmine dust standard of 7 mg/m3 of respirable dust
[13]. This standard was successfully introduced to the UK
Figure 3 Advert for ‘liquefied asbestos’ showing ill-advised use of an asbestos spray by a man with no personal protective equipment.
(From Asbestos focus website http://www.asbestosfocus.co.uk/apps/photos/photo?photoid=112479766).
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reduced prevalence of CWP. The USA took the same data
and developed their own standard of 2 mg/m3 respirable
dust (measured differently from the UK) which also pro-
duced enormous advantages in worker protection [14].
Throughout the middle and later twentieth century
there were similar attempts to determine safe levels of
asbestos and quartz, with varying success in terms of
getting the airborne levels lowered by adoption of tighter
standards over time This was often exacerbated by
resistance from industries to admitting the harmfulness
of the dusts and their reluctance to invest in costly dust
suppression equipment.
The rise of particle toxicology
Case reports and epidemiology usually have made the
first association between exposure to a dust and devel-
opment of disease, and epidemiology can explore the
exposure-response relationship that is so necessary for
standard setting. However toxicology can also make a
valuable contribution to prove that an exposure is indeed
the cause of a disease using Koch’s postulates type of
arguments. Additionally, as discussed later it can be used
to analyse the properties of particles that make them
harmful, something that is difficult to do in the mixed
exposures in human populations, and can thus provideinformation on mechanisms. E.J. King can justifiably be
seen as the first major UK particle toxicologist, although
he was a Canadian by birth [15]. Between the middle
1940s and the early 1960s he systematically demon-
strated silicosis in rats exposed to quartz and mixed
dusts [16-18], its modification with aluminium com-
pounds [19], the effects of asbestos on rat lungs [20] and
the effects of particles on cells in culture [21]. Early
theories of the mechanisms of quartz toxicity divided
into 2 camps—the solubility theory and the mechanical
theory. It is interesting to note that the Canadian group
of Denny and co-workers, in pursuit of the solubility
theory, had demonstrated a protective effect of alumin-
ium on silicosis in rabbits in the late nineteen thirties
[22] (Figure 5).
The solubility theory was based on the idea that sol-
uble silicic acid released from the quartz surface was the
harmful component, whilst the mechanical theory impli-
cated the sharp and angular quartz particles as mechan-
ically irritating the lungs [23]; neither of these paradigms
has survived to present day particle toxicology.
The first real mechanistic particle toxicology work on
asbestos had an emphasis on the quantification of dose,
a vital step, and was carried out by Dr Chris Wagner.
Whilst working as a young pathologist in Johannesburg,
Wagner had noted pleural mesothelioma, a very unusual
Figure 4 Gough Wentworth paper- mounted thick sections of
the entire lung of a non-smoking non-miner (left) and a coal
miner with cavitating progressive massive fibrosis (right). The
left hand lung shows some centri-acinar dust accumulations in the
upper parts related to air pollution but is otherwise normal. The
miner’s lung shows the dark pigmentation of coalmine dust with
emphysema and almost total destruction of the upper lobe with
apical pleural thickening. (with permission from Ingelheim portfolio
11 Lung sections).
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the Cape Province of SA and reported this in 1960 [24];
this established the first clear link between asbestos
exposure and its hallmark tumour, though earlier reports
had noted a connection. He then came to the UK to
work in the MRC pneumoconiosis unit in Llandough,
Wales. By 1965 Wagner began publishing an influential
series of papers beginning with asbestos deposition and
retention, the first emphasis on the modern concept of
particle dosimetry [25]. He went on to demonstrateFigure 5 (Left) Earl Judson King (1901–1963) and (right) a
figure from his 1946 paper [20] of a fibrotic lung lesion in a rat
exposed to asbestos fibre clearly showing a ferruginous body
(a coated asbestos fibre; arrow) in the lesion and multinucleate
giant cells. (Used with permission J. Clin. Pathol).mesothelioma production in rats after exposure to cro-
cidolite [26] and then carry out a number of long term
rat inhalation studies that set a new standard for this
type of study [27-30] exploring the role of asbestos types
and their mechanisms. Similar work was carried out in
the Institute of Occupational Medicine in Edinburgh led
by Dr John M.G. Davis from the mid-seventies onwards.
The Davis group went on to produce a sequence of im-
portant papers on the relationship between asbestos
characteristics and pathogenicity [31-34], many of which
were inspired and executed by Rob Bolton, whose PhD
had been supervised by John Davis in the early seventies.
In the USA at the same time, Merle Stanton at the
National Cancer Institutes was studying mesothelioma
induction by asbestos in rats using an implantation tech-
nique onto the visceral pleura. The Wagner, Davis and
Stanton groups all identified critical roles for fibre type
and length, igniting a substantial amount of research on
the role played by length, fibre type and biopersistence
in toxic potency that continues to the present day and
which has defined the first real structure:toxicity model
for a pathogenic dust [35-37]. In addition this work was
important from a practical point of view in terms of
defining exposure, since it allowed formulation of the
fibre-counting rules and led to the Walton Beckett grati-
cule [38] which assists in the identification of respirable
fibres. This enabled a scientific method of fibre counting
and thus regulation of the exposure to fibres in work-
place air.
Following on from Stanton’s work, in Germany Frie-
drich Pott and co-workers championed the use of the
intraperitoneal test as a sensitive assay for the potential
of fibres to cause mesothelioma. The use of the intraper-
itoneal test has, however, proved a controversial issue,
although it has become established in European regula-
tion (Figure 6).
Particle toxicology comes of age
By the late seventies the pace in particle toxicology was
quickening and there was a burgeoning community of
particle toxicologists, heralding the dawn of cellular toxi-
cology and applying its techniques to cells in culture as
the new methods became available. The first in the
series of meetings, still ongoing, then named ‘In vitro
effects of mineral dusts’ was held in 1979 (see [5] for the
history of this meeting). This era witnessed the first
attempts to find predictive tests for toxic particles,
although the understanding of the key pathological pro-
cesses such as fibrosis and cancer was not sufficiently
advanced for assays to be soundly based on an under-
standing of the molecular pathology. In fact the Proceed-
ings of the first meeting, held in Cardiff in 1979 [39],
were dominated by papers measuring cell death, since
that was about all that could be quantified! A few
Figure 6 Left Dr Chris Wagner (1923–2000) MRC Pneumoconiosis Research Unit, Llandough; (From the website of the Mesothelioma
Interest Group http://imig.org/about/wagner-award-recipients-2). Right Dr John M.G. Davis (1935–2011) Institute of Occupational
Medicine, Edinburgh. Property of KD).
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e.g. the use of a control, harmless particle like TiO2 and
a positive particle like quartz to allow benchmarking of
any unknown particles under test. Organ culture was
also used and Brooke T. Mossman [40] in the University
of Vermont used hamster trachea to demonstrate the
effects of asbestos and went on to investigate the mo-
lecular mechanism involved in asbestos effects over the
next 30 years, pioneering the oxidative stress theory and
demonstrating the molecular pathways by which parti-
cles influence cells. By the early eighties Arnold Brody in
the National Institute of Environmental Health Sciences
in North Carolina was using novel and creative electron
microscopy approaches to open up the ‘black box’ of the
lung with regard to the early responses to pathogenic
dust inhalation. Brody demonstrated that there was high
efficiency deposition of inhaled respirable fibres in the
centri-acinar and alveolar duct regions of rats [41,42]
leading to high localised dose and a rapid pathobiological
response [43,44]. David Warheit, later of DuPont, worked
in NIEHS at this time and was involved in these ground-
breaking studies [45], which were the first to demonstrate
the rapidly evolving response to a pathogenic dust in this
sensitive area, identifying the mechanism of macrophage
recruitment to sites of fibre deposition, followed by prolif-
eration of epithelial and other cells and prototypic fibrotic
lesion development at the first alveolar duct bifurcation.
In the meantime, in the eighties and nineties new par-
ticles came along to occupy particle toxicologists as
the ‘big three’ became better understood. These were the
man-made mineral fibres (MMMF), later renamed man-
made vitreous fibres (MMVF) and even later renamed
synthetic vitreous fibres (SVF). Some of the SVF were
seen as direct replacements for banned asbestos, to fill
the gap in the industrial need for fibres, but were still
fibres and so suspicion arose that asbestos might bebeing replaced by a similar hazard. These SVF, glasses
and ceramics of various sorts that are spun or blown
out into fibres, are used for insulation and numerous
other purposes. Many studies carried out comparisons
between asbestos and the vitreous fibres, culminating in
the emergence of ‘biopersistence’ as a key explanatory
attribute for discriminating between carcinogenic and
non-carcinogenic long fibres [46,47]. This era culminated
in the IARC Working party on the carcinogenesis of
these materials in 2001 [48]. The outcome of these delib-
erations was that biopersistence dominated; the non-
biopersistent SVF were exonerated as carcinogens and
the more biopersistent ones were classified as carcino-
gens. A side-effect of the discovery of biopersistence as a
key factor in SVF pathogenicity was the uncovering of
biopersistence as the explanation for differences between
the more harmful amphibole asbestos and the less harm-
ful chrysotile asbestos, the latter having been shown to be
less persistent both in vitro and in vivo. This period
showed the first full application of a number of tests in
particle toxicology that are now standard, including geno-
toxicity tests such as the micronucleus assay and the rise
of the measurement of cytokines and use of bronchoal-
veolar lavage to study lung inflammation and understand
mechanisms of inflammation development. It also wit-
nessed the development of a benchmark standard that
still pertains today for particle/fibre inhalation studies in
the form of the studies by the Research and Consulting
Company (RCC) on SVF [49,50]. These emphasised ex-
posure to respirable diameter fibres of the length found in
workplaces, lung burden studies, non-destructive aerosoli-
sation, accurate bimodal fibre counting, bronchoalveolar
lavage (BAL) etc. Similar but smaller—scale inhalation
studies performed in Edinburgh under the auspices of
the Colt Fibre Research Programme in the Institute of
Occupational Medicine in the early nineties came to the
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tence in fibre toxicity [51-53].
Ambient particles
By the middle nineties, with SVF receiving less research
attention in the wake of the IARC rulings, environmen-
tal particles (PM10) became of increasing interest for
particle toxicologists. The prevention of coal burning
in urban areas by the enactment of the Clean Air Acts
in the UK and elsewhere, had largely eliminated the
dense winter smoke fogs that saw epidemics of thou-
sands of deaths, as in the ‘great smog’ of 1952 in Lon-
don, and there was a feeling that the problem of
pollution in cities had been largely solved. However,
epidemiological studies of huge populations, entire
cities, began to show correlations between death rates
and concentrations of particles and sulphur dioxide in
the air. The studies revealed a short-term relationship
between these two variables in ‘time-series’ studies and
more long-term effects of living in polluted areas in
longitudinal studies. The most famous of the latter type
was the study which examined six US cities that had
different average levels of particulate air pollution and
showed that death rates in each city were related to the
concentrations of the particulate air pollution [54]. It
seemed that, although the visible soot-laden air that
had characterised cities since earliest times was no
longer evident, the increase in traffic had brought a
new kind of air pollution derived largely from combus-
tion in vehicle engines.
By the early 1990s it was apparent that although the
mass of particles in air pollution had fallen dramatically
in industrial societies in the West, effects on health in
terms of heart and lung disease were still apparent,
though by now the predominant source of the pollution
had changed from coal burning to vehicles. The intro-
duction of new statistical techniques made it possible to
demonstrate that relatively small fluctuations in pollu-
tion concentrations were associated with similarly small
fluctuations in health effects, from heart attack deaths to
consultations with doctors for exacerbations of asthma.
Whether these effects derived from particles or toxic
gases was a major issue, particularly in terms of what to
regulate, but the most remarkable fact was the low con-
centrations at which the associations were observable.
It was notable that although as one might expect
respiratory illness occurred, the greater number of
deaths and hospitalisations occurred from heart disease,
usually heart attack [55]. This fact, that an organ distant
from that in which the toxic agent was deposited was
the one most affected seemed paradoxical and was an
obvious challenge to toxicology. As research advanced,
particles were seen to act by a variety of pathways to
induce inflammation and oxidative stress in the lungs[56-58], making the link to exacerbations of airways dis-
ease and even possibly lung cancer, though the epidemi-
ology on this was, at the time, weak. The question as to
how pulmonary deposition of extremely low concentra-
tions of mainly carbon particles might cause heart
attack was first addressed in a hypothesis paper that
emanated from a discussion in 1994 between the
authors, David Godden and Bill MacNee. Seaton, fol-
lowing a conversation with Robert Waller in 1993,
chanced upon a paper on seasonal plasma fibrinogen
fluctuations and it immediately occurred to him that
pollution exposure might act through such an amplify-
ing mechanism that might lead to cardiovascular deaths
by promoting clotting in the coronary arteries. The
question of low dose was addressed by thinking in terms
of numbers rather than mass. It had been known since
the 19th century that air pollution contained many very
small particles, and this was demonstrated by the Law-
ther and Waller group in the 1960s. The highly original
work of Ferin and Oberdorster and colleagues had
shown unexpected increases in toxicity of ultrafine par-
ticles, or what are now generally characterised as nano-
particles [59]. Thus we were able to propose that
‘. . .inflammation provoked by ultra-fine particles, in
addition to promoting exacerbations of lung disease,
has an additional effect on the coagulability of blood,
increasing the susceptibility of individuals to acute
episodes of cardiovascular disease. . .’ [55]. This brief but
highly–cited paper preceded a huge research effort and
clear evidence of a link from the lungs to the blood ves-
sel wall and the atherosclerotic plaque subsequently
emerged in many studies, for example using ApoE
mice [60] and human chamber studies [61]. In fact a
persuasive mechanism has emerged based on relatively
low exposures of human subjects to diesel exhaust parti-
cles (DEP) inducing lung inflammation and oxidative
stress. These indirectly affect cardiac blood flow, [62] the
associated endothelium [63,64] and the clotting system
[65] in ways that favour atherothrombosis. These data
have emerged from a fruitful collaboration between
Edinburgh University (Professor David Newby, Dr Nick
Mills), University of Umea in Sweden (Professor Thomas
Sandström, Professor Anders Blomberg) and the RIVM in
the Netherlands (Professor Flemming Cassee). The overall
approach utilises cells, rodent and human studies in a
highly innovative model program aimed at determining
the link between pulmonary deposition of diesel particles
and atherothrombosis. Whilst indirect effects of inflam-
matory mediators and oxidants from the lung means that
a role for translocation of the combustion-derived nano-
particles to the blood in driving these events seems to be
receding, translocation still remains an open question.
This emphasis on diesel exhaust nanoparticles is not
meant to detract from the likelihood that the fine and
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effects of PM depending on the origin of the particles
and their chemical composition e.g. [66].Figure 7 Royal Society and Royal Academy of Engineering
report ‘Nanoscience and nanotechnologies: opportunities and
uncertainties’ published in 2004.Nanoparticle toxicology /nanotoxicology
The 1990s saw extraordinary advances in technology
which gave rise to the possibilities of engineering materi-
als at sub-micron scale and thereby producing new
materials with specifically enhanced or altered proper-
ties, nanotechnology. It was foreseen that this would
open up a whole new world of industrial and commer-
cial applications, but at the same time concerns began
to be expressed that some of these altered properties
might imply altered or enhanced hazard to humans or
the natural environment. The UK government asked the
Royal Academy of Engineering and the Royal Society
to consider these opportunities and uncertainties. At the
same time the term nanotoxicology was coined in a
commentary by Robert Service in the journal Science
in 2004 [67] and a number of European particle toxi-
cologists, led by one of us (KD), laid out what amounted
to a manifesto on this new area of particle toxicology
in an Editorial in the UK journal Occupational and
Environmental Medicine entitled ‘Nanotoxicology: A
new frontier in particle toxicology relevant to both the
workplace and general environment and to consumer
safety’ [68]. This concern about new manufactured
nanoparticles (MNP) being developed in industry was
predicated on the experience of particle toxicology
which had shown that surface area and reactivity were
important determinants of toxicity and which had sug-
gested that combustion-derived nanoparticles were a
main factor in ambient particle toxicity (see [4]for a
fuller history and the origins of nanotoxicology). The
possibility that new nanotechnologies might produce
other materials posing similar hazards to asbestos or air
pollution particles was a powerful driver in raising the
concerns that were crystallised in the influential report
of the UK Royal Academy of Engineering and Royal
Society [69] (Figure 7).
There has been an enormous amount written on the
issue of nanotoxicology, much of it generating more heat
than light, but it remains at the time of writing the pri-
mary concern for particle toxicologists, and the primary
source of funding. Carbon nanotubes for example have
been found to be highly fibrogenic in the lungs [70] and
if they are in a fibrous morphology, to have the potential
to produce asbestos-like effects in the peritoneal and
pleural spaces [71,72]. These toxicological findings have
already influenced risk assessment and standard setting
in relevant workplaces.
It is interesting to observe that prior to the develop-
ment of manufactured nanoparticles (MNP), concernthat a particle could have an adverse effect tended to
develop in the following way:
1. a single or a few cases were reported in a workforce
who handled and were exposed to a specific particle.
2. toxico-pathological studies suggested a causative
relationship between the material inhaled
and disease.
3. epidemiological investigations demonstrated the
nature of the relationship and possibly estimated
an exposure-response relationship.
4. toxicologists confirmed and further enhanced
understanding by controlled animal experimentation
and explored the molecular mechanism using
cell models.
5. particle toxicologists examined the role of the
particle structure in the toxicity.
It is striking however, that for MNP this process is
working the other way round. Many MNP under study
are in general not yet being handled in large enough
quantities or for long enough for disease to emerge.
Therefore toxicologists are trying to predict the diseases
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to MNP before there is any evidence that they are occur-
ring or will occur. This would seem to be an improve-
ment on waiting to ‘count bodies’ on the introduction of
a new hazard. However, it does raise the possibility of
false positives especially if significant exposures do not
occur. This is new territory and the predictive power of the
assays we use are being themselves tested to the breaking
point while exposure data need to be integrated with the
toxicological data to decide risk—not an easy process. It
remains to be seen how this will all resolve and which if
any nanomaterials represent significant risk.
Cigarette smoke
Cigarette smoke certainly exceeds ‘the big three’ in
terms of the ill health that it has caused but, apart from
a smattering of papers in the early years, particle toxicol-
ogy has not embraced cigarette smoke. This has become
even more marked in the last 20 years, when the ability
to publish toxicological (as opposed to epidemiological)
research on cigarette smoke effects has been greatly
impaired and those studying cigarette smoke, or taking
funds for that purpose, have become to an extent margin-
alised by the scientific community. To our knowledge no
papers on cigarette smoke have ever appeared in the
journals Particle and Fibre Toxicology nor in Nanotoxi-
cology and very few have ever appeared in the Inhaled
Particles series or the Particle Toxicology series. From the
point of view of toxicology the relationship between the
main pathological consequences in the lungs—cancer and
COPD—and particulate versus the gaseous and organic
phases is not resolved and particles themselves may not
play the primary role. Cigarette smoke remains a marginal
issue for particle toxicologists and one that has compli-
cated political and social issues related to it.
The dose in particle toxicology
It seems important to finish on ‘dose’, the most pertinent
entity in toxicology. In particle toxicology, good dosimetry
and the ‘biologically effective dose’ have proved elusive.
Tissue burdens, including mass balance toxicokinetics,
are necessary in order to understand the complete picture
of any toxin, especially the role of the translocated dose
that reaches beyond the portal of entry and its mechan-
ism and consequences. This was seldom done in an inte-
grated way in particle toxicology until the emergence of
a key German/USA collaboration. This collaboration,
between Gunter Oberdörster and Wolfgang Kreyling has
been central to the current view of particle dosimetry that
dominates the discipline. Oberdörster worked in the
Fraunhöfer in Hanover but relocated to the University of
Rochester in the 1980s where there was already strength
in depth in particle toxicology through the work of Juraj
Ferin and Paul Morrow. Kreyling was, and still is,employed at the Helmholtz near Munich with a large
lung dosimetry group which originally included particle
toxicologists such as Helmut Greim and Joachim Heyder.
Kreyling’s strength in mass balance particle toxicokinetics
was matched by Oberdörster’s insightful and skilful com-
mand of toxicology and between the two of them they
virtually invented modern particle dosimetry.
This has an emphasis on quantitative aspects of par-
ticle dose including the dose rate, the need to under-
stand deposition, clearance and translocation and their
relation to pathobiological mechanisms and the response
seen at the tissue and cell level, in the lungs and beyond.
Postscript
The era of particle toxicologists who originally saw coal-
mine dust, quartz and asbestos as the big problem and
were involved in the invention of particle toxicology as a
discipline is almost over. Nanotoxicology now dominates
particle toxicology and for many people nanoparticle
toxicology is particle toxicology. In fact the issues sur-
rounding the big three have never been fully resolved
and there remain many unanswered questions in con-
ventional particle toxicology. For example, why is erio-
nite so potent a cause of mesothelioma? What is the
mechanism of quartz toxicity? Why do only rats get
overload? The avalanche of funding that flowed into
nanotoxicology will end soon, new particles and new
issues will arise, and many questions remain in conven-
tional particle toxicology, so there will always be a place
for particle toxicologists. Multidisciplinarity has always
been a feature of particle toxicology and this has been
enhanced with the rise of nanotoxicology. The emphasis
placed on particle characterisation in nanotoxicology has
increased the need for particle toxicologists to work with
chemists, physicists and material scientists. It is hoped
that the outcome of this is that we edge nearer to a
structure-toxicity relationship, the “philosopher’s stone”
of particle toxicology. The realisation of a full structure-
toxicity model would mean that determination of the
physicochemical properties of a new particle would
enable its toxicity to be predicted without recourse to
animal or cell experiments.
While particle toxicology remains a niche area it now
has its own specific journals—Particle and Fibre Toxicol-
ogy and Nanotoxicology; other nanomaterial journals also
accept papers on nanotoxicology whilst particle toxicology
papers occasionally make it into the general molecular
medicine literature. It is to be hoped that having our own
journals helps our general profile and that the Impact
Factors for these journals continues to increase.
Those new to particle toxicology are encouraged to
consult the series of Proceedings of the rolling meetings
on particle toxicology that is mentioned earlier in this
review (see review [5]) to gain more detailed insight into
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ested. If you are reading this then you are probably con-
tributing to what will become the history of particle
toxicology in the future and we hope that this short his-
tory has helped to place the subject in context.
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